| Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis AV Ramanan, AD Dick, AP Jones, A McKay, PR Williamson, ... New England Journal of Medicine 376 (17), 1637-1646, 2017 | 401 | 2017 |
| An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood C Edelsten, V Lee, CR Bentley, JJ Kanski, EM Graham British Journal of Ophthalmology 86 (1), 51-56, 2002 | 285 | 2002 |
| Visual loss associated with pediatric uveitis in English primary and referral centers C Edelsten, MA Reddy, MR Stanford, EM Graham American journal of ophthalmology 135 (5), 676-680, 2003 | 281 | 2003 |
| Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative T Constantin, I Foeldvari, J Anton, J De Boer, S Czitrom-Guillaume, ... Annals of the rheumatic diseases 77 (8), 1107-1117, 2018 | 208 | 2018 |
| Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors A Heiligenhaus, C Heinz, C Edelsten, K Kotaniemi, K Minden Ocular Immunology and Inflammation 21 (3), 180-191, 2013 | 193 | 2013 |
| Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program A Chia, V Lee, EM Graham, C Edelsten American journal of ophthalmology 135 (6), 757-762, 2003 | 146 | 2003 |
| A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile … AV Ramanan, AD Dick, D Benton, S Compeyrot-Lacassagne, D Dawoud, ... Trials 15, 1-13, 2014 | 132 | 2014 |
| Changes in the levels of soluble adhesion molecules and coagulation factors in patients with deep vein thrombosis A Smith, JW Quarmby, M Collins, SM Lockhart, KG Burnand Thrombosis and haemostasis 82 (12), 1593-1599, 1999 | 94 | 1999 |
| Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis–associated uveitis: a consensus effort from the multinational interdisciplinary … A Heiligenhaus, I Foeldvari, C Edelsten, JR Smith, RK Saurenmann, ... Arthritis care & research 64 (9), 1365-1372, 2012 | 93 | 2012 |
| The ocular and systemic prognosis of patients presenting with sarcoid uveitis C Edelsten, A Pearson, E Joynes, MR Stanford, EM Graham Eye 13 (6), 748-753, 1999 | 72 | 1999 |
| Acute angle closure glaucoma: relative failure of YAG iridotomy in affected eyes and factors influencing outcome. SA Buckley, B Reeves, M Burdon, C Moorman, S Wheatcroft, C Edelsten, ... British journal of ophthalmology 78 (7), 529-533, 1994 | 61 | 1994 |
| The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis LJ Howe, MR Stanford, C Edelsten, EM Graham Eye 8 (4), 443-447, 1994 | 59 | 1994 |
| Visual impairment, severe visual impairment, and blindness in children in Britain (BCVIS2): a national observational study LJ Teoh, AL Solebo, JS Rahi, J Abbott, W Abdullah, G Adams, L Allen, ... The Lancet Child & Adolescent Health 5 (3), 190-200, 2021 | 50 | 2021 |
| Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell … P Hiwarkar, E Gajdosova, W Qasim, A Worth, J Breuer, R Chiesa, ... Clinical infectious diseases 58 (12), 1700-1706, 2014 | 48 | 2014 |
| Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience RAG Russo, S Melo-Gomes, HJ Lachmann, K Wynne, K Rajput, ... Rheumatology 53 (4), 665-670, 2014 | 48 | 2014 |
| The risk of complications of uveitis in a district hospital cohort R Maini, J O’Sullivan, A Reddy, S Watson, C Edelsten British journal of ophthalmology 88 (4), 512-517, 2004 | 48 | 2004 |
| Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis AG Zaman, C Edelsten, MR Stanford, EM Graham, BA Ellis, H Direskeneli, ... Clinical & Experimental Immunology 95 (1), 60-65, 1994 | 46 | 1994 |
| Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures … I Foeldvari, J Klotsche, G Simonini, C Edelsten, ST Angeles-Han, ... Pediatric Rheumatology 17, 1-14, 2019 | 45 | 2019 |
| Serpiginous choroiditis: an unusual presentation of ocular sarcoidosis. C Edelsten, MR Stanford, EM Graham The British Journal of Ophthalmology 78 (1), 70, 1994 | 45 | 1994 |
| Are cytokine gene polymorphisms associated with outcome in patients with idiopathic intermediate uveitis in the United Kingdom? MR Stanford, RW Vaughan, E Kondeatis, Y Chen, CE Edelsten, ... British journal of ophthalmology 89 (8), 1013-1016, 2005 | 38 | 2005 |
Paula R WilliamsonVerified email at liv.ac.uk
